Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin FamilyMatthew A. Gregory, Barrie Wilkinson, Nigel J. Coates et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 54
Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infectionSteven J. Moss, Matthew A. Gregory, Michael Bobardt et al.|MedChemComm|2011Cited by 26